1. Current Diagnosis Patterns for Acute Myeloid Leukemia: Concordance Between Clinical Practice (Connect® Disease Registry) and Who 2008 Recommendations. (April 2017) Authors: George, T.I.; Erba, H.P.; Pollyea, D.A.; Abedi, M.; Roboz, G.J.; Thompson, M.A.; Fliss, A.; Swern, A.S.; Nifenecker, M.; Kiselev, P.; Sugrue, M.M.; Foucar, K. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Enasidenib (AG-221), A Selective Oral Inhibitor of Mutant Isocitrate Dehydrogenase 2 (IDH2) Enzyme, In Patients with Myelodysplastic Syndromes (MDS). (April 2017) Authors: Stein, E.M.; Fathi, A.T.; DiNardo, C.D.; Pollyea, D.A.; Swords, R.T.; Roboz, G.J.; Collins, R.; Sekeres, M.A.; Stone, R.M.; Attar, E.C.; Tosolini, A.; Xu, Q.; Amatangelo, M.; Gupta, I.; Knight, R.D.; de Botton, S.; Tallman, M.S.; Kantarjian, H.M. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML). (April 2017) Authors: Savona, M.R.; Garcia-Manero, G.; Roboz, G.J.; Walsh, K.J.; Kropf, P.L.; Issa, J.P.; O'Connell, C.L.; Tibes, R.; Yee, K.W.L.; Stock, W.; Lunin, S.; Berdeja, J.G.; Naim, S.; Hao, Y.; Azab, M.; Kantarjian, H. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗